The effect of selenium in patients with Covid-19

Phase 3

• Conditions: COVID-19.; COVID-19, virus identified; U07.1

• Registration Number: IRCT20160919029870N3
• Lead Sponsor: Ghoum University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 November 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Patients diagnosed with Covid-19 disease by infectious disease physician
Patients who are hospitalized in the special ward and three days have been passed since their hospitalization
Patients who are intubated and connected to a ventilator

Exclusion Criteria

Patients with covid-19 who are not intubated.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Duration of hospitalization. Timepoint: The first day of patients' arrival and the day of discharge from the ICU or death of patients. Method of measurement: Number of days patients are admitted to the ICU.

Secondary Outcome Measures

Name	Time	Method
Death. Timepoint: Daily from the day of admission to the special ward until discharge or death of patients. Method of measurement: Document.